Scheme

SBI Healthcare Opportunities Fund

Holds 35 companies worth ₹5,608 Cr in Sept 2026.

  • Fund house

    SBIThe fund house that runs this scheme.
  • AUM

    ₹5,870 CrSBI Healthcare Opportunities Fund's AUM at the end of 30 Sept 2026, as AMFI reports it. Up 1.3% on Aug 2026, ₹5,796 Cr.
  • Largest holding

    Sun Pharmaceutical Ind LtdSun Pharmaceutical Ind Ltd is 11.1% of this scheme's NAV.
  • Fund manager

    Tanmaya DesaiRuns it since 27 Jun 2011, as the fund house dates it.

AUM(Jun 2010 – Sept 2026)

AUM at month end each month, and its change on the month before
12 months₹ CrChange
Sept 20265,870+1.3%
Aug 20265,796+7.3%
Jul 20265,400+8.0%
Jun 20264,998+9.5%
May 20264,564+5.6%
Apr 20264,323+6.4%
Mar 20264,064−0.3%
Feb 20264,077+6.6%
Jan 20263,824−4.1%
Dec 20253,989−3.4%
Nov 20254,131+1.2%
Oct 20254,082+3.8%
AUM at month end, Sept 2026
₹5,870 Cr
+43.8% since Oct 2025
Fig. 1.AUM at each month's end, ₹ crore; under All, the quarterly average since 2010. Source: AMFI.

Direct plans(Mar 2013 – Sept 2026)

Direct plans' share of AUM each quarter, and its change on the quarter before
4 quartersShareChange
Sept 202636.70%+1.64 pt
Jun 202635.06%+2.20 pt
Mar 202632.86%+0.29 pt
Dec 202532.57%+0.46 pt
Direct plans' share of AUM, Sept 2026
36.70%
+4.13 pt since Dec 2025
Fig. 2.SBI Healthcare Opportunities Fund's quarterly average AUM in direct plans, which pay no distributor; changes in points. Source: AMFI.

Returns(9 Oct 2026)

Growth · Direct and Regular plans

To 9 Oct 2026; past a year, a yearly rate. Benchmark: BSE Healthcare TRI. * From NAVs. Source: AMFI. Click a column's header to sort by it.
1 month *
−5.71%−5.79%––−4.51%
3 months *
−0.16%−0.40%––−3.15%
6 months *
+18.47%+17.90%––+4.22%
1 year
+16.20%+15.04%+10.89%+5.30 pt+0.43%
3 years
+22.64%+21.39%+21.02%+1.62 pt+12.61%
5 years
+17.53%+16.31%+13.93%+3.60 pt+11.64%
10 years
+14.37%+13.13%+12.32%+2.04 pt+13.94%
Since launch
+17.78%+15.34%+14.55%+3.23 pt+13.17%
Fig. 3.To 9 Oct 2026; past a year, a yearly rate. Benchmark: BSE Healthcare TRI. * From NAVs. Source: AMFI.